Introduction
Falciparum malaria is a complex multi-organ disease. There is no simple or accepted explanation for how small numbers of parasites can cause such severe illness, or how this infection can cause such wide-spread pathology, since only hepatocytes and erythrocytes are invaded by the pathogen. Undoubtedly parasitized red cells sequester in capillaries and venules, but in recent times the traditional idea that this is the primary cause of organ failure and death through obstructing blood flow has needed modifying. In particular, it has had to accommodate the evident involvement of excessive systemic release of pro-inflammatory cytokines, triggered by malarial toxins. For the last decade, many researchers have focussed their efforts on the pathophysiological implications of the ability of these mediators to generate inducible nitric oxide synthase (iNOS), and thus produce a continuous, potentially large, supply of nitric oxide in tissues that normally experience only low, tightly controlled, levels of this ubiquitous cellular messenger. Despite the harmful effects of iNOS-induced nitric oxide (NO) when produced in unusually large amounts [
1‐
3], more commonly it provides negative feedback that suppresses production of the inflammatory cytokines that generate it, and a range of other downstream harmful mediators, through inhibiting NF kappa B, a major activator of protein transcription [
4].
Carbon monoxide (CO), another endogenous gas with a similar structure, also inhibits TNF generation [
5] again through inhibiting NF kappa B [
6]. Both molecules are generated by enzymes that have at least one constitutive form, and another, iNOS and haemoxygenase-1 (HO-1) respectively, induced by inflammatory cytokines. NO and CO act interactively as second messengers in ways that are still being elucidated [
7]. For instance, both NO and CO can activate soluble guanylate cyclase to generate cyclic GMP [
8], and thus dilate blood vessel walls, as well as perform their immunosuppressive roles.
This shared activity of NO and CO duplicates that of interleukin-10 (IL-10), the prototype anti-inflammatory cytokine, which also suppresses generation of tumour necrosis factor (TNF) and interleukin-1β through inhibiting NF kappa B [
9]. Thus the high circulating levels of IL-10 seen in human malaria [
10,
11] and sepsis [
12], have been proposed to suppress disease severity through inhibiting the systemic inflammatory effects of TNF [
13]. These apparently disparate observations are now appreciated to be different parts of the same chain of events, with IL-10 producing its strong anti-TNF effect through inducing HO-1, and thus generating CO [
14]. The most plausible explanation for the early observation that TNF induces HO-1 [
15] is now therefore its ability to induce IL-10 [
16]. Likewise, the anti-inflammatory effect of 15d prostaglandin J
2 (15d PGJ
2), which is present in tissues during inflammation [
17], also operates through HO-1 induction and subsequent generation of CO [
18]. As in sepsis, cyclooxygenase-2, which generates 15d PGJ
2, is induced in severe malaria [
19]. Thus, rather than HO-1 simply being a marker for haem degradation and a generator of anti-oxidant defences, it is now recognized to be an integral part of the network of inflammatory mediators. It therefore serves as a convenient and sensitive marker for such activity.
Accordingly, brain, lung and liver from 40 African children who had died of malaria, sepsis or unrelated conditions were stained for HO-1 in order to identify cellular sites where the CO-mediated anti-inflammatory activity of IL-10 might be located in these infectious diseases. These tissues had previously been stained for migration inhibitory factor (MIF) and inducible nitric oxide synthase (iNOS) [
20]. Before the IL-10 or prostaglandin links of HO-1 were appreciated, others [
21,
22] have immunostained brains, but no other tissues, from adult malaria cases, to detect this enzyme. The present study provides further evidence for the presence of multi-organ inflammatory changes in children fulfilling the clinical criteria of 'cerebral malaria', whether or not malaria was the principal or only pathological diagnosis.
Materials and Methods
Case Tissues
As described earlier [
20], all 40 subjects (age range six months to 12 years; 22 females) were children who had been admitted to the Malaria Project wards in the Department of Paediatrics at the Queen Elizabeth Central Hospital in Blantyre, Malawi (Table). Evaluation, diagnoses, treatment, autopsy permissions were as previously described [
20]. Autopsies were performed as quickly after death as possible, with post-mortem intervals ranging from two to 14.5 hrs. Tissue samples were placed into 10% neutral buffered formalin for fixation. The project was approved by the ethics and research boards of the College of Medicine (University of Malawi), the University of Liverpool and the Australian National University.
Control tissues
Tissues from three Malawian children who were enrolled in this study served as local non-comatose controls. No coma was present at any stage in two of these (patients 41 and 50; see Table). The former grew Salmonella typhimurium from cerebrospinal fluid and blood, and died, having been alert a short time before, after an acute gastrointestinal haemorrhage, and the other grew scanty Streptococcus pneumoniae from the cerebrospinal fluid. The third (patient 43) had been diagnosed as cerebral malaria but, after recovering to an alert state, died from a cardiopulmonary arrest. In addition, various adult controls from Australian sources were studied. These comprised sections of five blocks of tissue, trimmed from the periphery of tumour excisions from adult chest wall, and containing skeletal muscle, adipose tissue and small blood vessels. Midbrain sections from three adults who had died of coronary artery disease, and from another three who died of non-infectious, non-cerebral conditions (Brain Bank for Sydney Central Area Health Science Approval X980216), were also stained. A section of an inflamed pilonidal sinus was routinely included as a positive control.
Immunohistochemistry
Formalin-fixed tissue samples were embedded in paraffin, sectioned (4 microns) on to polylysine-coated slides, and stained with haematoxylin and eosin (H&E) for routine morphology. A monoclonal anti-HO-1 antibody was purchased from StressGen; (Cat. No. OSA-110). Other monoclonals were used as irrelevant primary control antibodies, and in other controls the primary antibody was omitted. As previously [
20], antigen retrieval was performed by immersion in 0.01 M citrate buffer, pH 6.0, in a waterbath at 95°C for 20 min and then cooling to room temperature while still immersed in buffer. After quenching with 3% H
2O
2 and treating with primary antibody (dilution of the stock solution 1:500 to 1:2000) at room temperature for 1 hr, biotin-conjugated secondary antibody and streptavidin-conjugated horseradish peroxidase from an LSAB
+ kit (DAKO) were applied to sections for 20 min at room temperature to amplify the antigen signal for subsequent 3,3'-diaminobenzidine (DAB) staining. Known positive controls were stained in each run, and runs were often duplicated on different days to confirm repeatability. Sections were counterstained with haematoxylin, and outcomes with a dilution of primary antibody of 1:1000 are shown to illustrate the observed changes. Anti-CD68 antibody (Clone PG-M1) was obtained from DAKO, and used, with antigen retrieval, at a primary antibody dilution of 1:500.
Histological examination
In a recent investigation of the distribution of MIF and iNOS [
20], in which 32 cases that had been clinically diagnosed as cerebral malaria were studied, they were classified into three categories on the basis of the presence or absence of sequestered intracerebral parasites and brain pathology. Category A (n = 11) had no or scanty intracerebral parasites and negligible brain pathology detected, category B (n=seven) had sequestered parasites in brain vessels, again with negligible brain pathology, and category C (n = 14) had both sequestered parasites and inflammatory brain pathology in the form of intravascular monocyte aggregations, fibrin deposition and/or microhaemorrhages. Here this same terminology is retained, and the outcome of immunostaining to detect HO-1 in the brain, lung and liver of these same cases is reported. In most of the category A patients, autopsy revealed another likely cause of death: this was pneumonia in five cases, hepatic necrosis in one, severe anaemia with pulmonary oedema in one, and ruptured cerebral aneurysm in one. No alternative causes were identified in category B and C patients.
One hundred and forty sections from 49 brains were stained for HO-1 and examined. Samples were from frontal lobe, parietal lobe, temporal lobe, occipital calcarine fissure, hippocampus, caudate nucleus, basal ganglia, thalamus, midbrain, pons and medulla, with frontal lobe, occipital region, midbrain and pons most commonly included. Two sections were considered ample to record a result on sections where staining was readily detected, since up to seven were examined in some cases, with no difference in outcome from the opinion formed after the first section. Up to seven sections per brain were examined in those cases with no staining detectable, and these comprised sections from two to four blocks, which provided an element of depth within individual blocks as well as a spread of location across the brain. With few exceptions, staining was either absent, moderate, or strong, and if strong was sometimes remarkably intense and even, despite the high dilution of primary antibody. Mid-brain sections from three adults who had died of coronary artery disease, and from another three who died of non-infectious, non-cerebral conditions (Brain Bank for Sydney Central Area Health Science Approval X980216), were included. Single blocks only were available for lung and liver. Two examiners (IC and CH), blinded to the diagnosis, examined the sections independently.
Discussion
Here is described the cellular distribution of HO-1 in several key organs in African children who died of clinically defined cerebral malaria or coma accompanying a bacterial infection. Endothelial cells and vascular smooth muscle, and skeletal muscle, so often MIF and iNOS positive [
20], were devoid of HO-1. Previous reports of HO-1 staining of human tissues includes the cytotrophoblast cells within the placental bed of the normal human placenta [
23], the alveolar macrophages of normal and inflamed lung [
24], endothelium and macrophages of atherosclerosis lesions [
25], Kupffer cells and hepatocytes in portal hypertension [
26], tubular epithelial cells in kidney diseases [
27], and microglia and macrophages in focal cerebral infarcts and brain trauma [
28]. Malarial brains, but no other organ, from Asian [
22] and European adults [
21] have been stained for HO-1, and, consistent with the literature of the time, HO-1 was discussed only in terms of being a stress protein [
22] and a generator of CO that could contribute to cerebral malaria by influencing neurons directly [
21].
What induced HO-1 in these tissues remains unclear. It is well accepted that a high concentration of haem induces HO-1 [
29], and the invariable staining observed in spleen red pulp in all cases (not shown), and at cerebral haemorrhage sites where red cells have been phagocytosed (Fig.
3B) in category C brains is consistent with this. Haem from local haemorrhage cannot, however, account for the presence of HO-1 in mononuclear phagocytes in CM(A) or CM(B) brains, and other organs In addition, cellular deprivation of glucose has been shown to induce the HO-gene 1
in vitro [
30], raising the possibility of the hypoglycaemia sometimes seen in severe childhood falciparum malaria being instrumental in generating the observed HO-1. No difference was seen in the intensity of HO-1 staining between cases with normal peripheral blood glucose concentration and those with systemic hypoglycaemia, but this observation does not exclude local tissue hypoglycaemia as a possible stimulus to HO-1 induction. IL-10, a major modulator of inflammation increased in malaria [
10], is now known to induce HO-1 [
14]. Plasmas for IL-10 assay were not available from these cases, but the precedence exists of high levels being associated with severe malarial illness [
10,
11].
In view of the evidence that the inflammatory cascade is activated in this Malawian [
20,
31] and other [
32‐
34] populations with severe malaria infection, the observed HO-1 is additional evidence that in fatal malaria a widespread host inflammatory response occurs, similar to that seen in other acute infections (reviewed in [
35]). This is consistent with the HO-1 staining seen in the sepsis cases in this series (Fig.
4), in that systemic bacterial infections are broadly accepted to be examples of systemic inflammation. This is not to suggest that some of the cerebral malaria cases in this series did not have additional or alternative disease mechanisms, arising from local cerebral lesions, such as vessel obstruction from large parasite loads in the apparent absence of other lesions (Fig.
2B). Nevertheless, strong systemic inflammation was present in all these cases. Local cerebral changes arising from post-schizogony secondary inflammatory events, as demonstrated by the presence of monocytes accumulations, high iNOS, haemorrhages and fibrin in other CM(C) cases (Fig.
3A and
3B) may well also contribute significantly.
Taken with the evidence that eight of the 11 category A brains had no evidence of HO-1 staining, these results, along with the apparent absence of sequestration or monocytic accumulation (now reinforced by examining this large series of new sections) and iNOS staining in these same brains [
20], add to previous evidence [
20] that these 11 sets of brains sections, one third of the total from clinically diagnosed cases of cerebral malaria, were largely devoid of significant intravascular change. These patients, together with those in the group of patients with non-malarial comatose illness, illustrate the fact that coma may accompany infections with extensive systemic inflammation but without evidence of intracerebral inflammatory responses. It is, therefore, possible that, in the CM(B) and CM(C) patients (with cerebral sequestration and cerebral intravascular HO-1 induction), the observed widespread systemic inflammation may have been similarly important in the pathogenesis of coma. This adds strength to the argument that systemic events, not only those in the brain, should be borne in mind when attempting to understand disease outcome in African children clinically diagnosed with cerebral malaria. The CM(A) group, one third of the cases, in which malaria was only one of several conditions that could have contributed to death, might have provided insight into the state the cerebral vasculature of the CM(B) and CM(C) cases after they had become comatose, but some time before death.
Finally, the inhibitory activity of CO, the product of HO-1, against TNF [
4] parallels that of NO, the product of iNOS [
5]. Ideas on how iNOS polymorphisms might have been selected for in African populations [
36,
37] through their interaction with malarial disease might also, from these results, apply to known HO-1 polymorphisms [
38,
39] in these populations.
Acknowledgments
This work was supported by the Australian National Health and Medical Research Council, Grant 148902, the National Institute of Allergy and Infectious Diseases, USA (Grant 1-RO1-AI 34969) and the Wellcome Trust. We thank Dr Biziwick Mwale, Director of the Queen Elizabeth Central Hospital, and Professor Robin Broadhead, Department of Paediatrics of the College of Medicine, University of Malawi, for their hospitality and for access to patients in the Malaria Ward, and we thank Professor Terrie Taylor, who played a major part in running the Severe Malaria Ward and in arranging and conducting autopsies. We appreciate the cooperation of parents and guardians of the children studied, and the devoted care provided by the nursing and laboratory staff within the Paediatric Department and the research programme. This study received funding from the Australian Health and Medical Research Council, the National Institutes of Health, USA, and The Wellcome Trust, UK.